ADR120S, Inc.【JP:3750】Balance sheet

Market cap

¥7.9B

P/E ratio

110.7x

Saitori Cell Research Institute develops regenerative cell therapies and medical devices while also investing in real estate projects through seven subsidiaries.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Cash and cash equivalents	-	1,127	840	2,325	996	1,533	1,000	1,070	852	1,123	1,038	256
Marketable securities, current	-	-	-	-	-	-	-	-	138	-	-	-
Total cash & short-term investments	-	1,127	840	2,325	996	1,533	1,000	1,070	989	1,123	1,038	256
Inventories	-	101	90	35	-	-	-	-	-	-	-	-
Total current assets	-	4,459	3,834	2,801	3,128	7,256	6,480	6,270	3,029	1,388	1,428	517
Property, plant and equipment, net	-	168	11	6	2,218	6	7,662	7,467	12,041	11,727	4,218	2,960
Marketable securities, non-current	-	-	-	-	-	200	369	314	-	-	-	-
Total non-current assets	-	262	72	41	2,245	229	9,003	8,654	12,978	12,703	4,389	3,020
Total assets	-	4,721	3,906	2,841	5,374	7,485	15,483	14,924	16,007	14,092	5,816	3,538
Accounts payable	-	366	296	-	-	-	-	-	-	-	-	-
Short-term debt	-	282	218	-	2,200	280	27	-	164	500	70	300
Long-term debt, current	-	-	-	-	-	110	521	521	553	401	55	54
Total current liabilities	-	1,507	674	120	2,256	886	813	735	995	1,174	536	492
Total non-current liabilities	-	21	6	5	43	2,999	10,837	10,641	11,295	10,261	2,485	2,415
Total liabilities	-	1,528	680	125	2,298	3,884	11,650	11,376	12,290	11,435	3,021	2,907
Retained earnings	-	148	182	-282	167	1,257	1,442	543	463	-597	-459	-2,619
Stockholders' equity	3,031	3,193	3,226	2,717	3,075	3,601	3,833	3,548	3,716	2,657	2,796	631